Investing in research


In fiscal year 2008–2009, Emory's Woodruff Health Sciences Center (WHSC) was awarded $446.5 million in research funding, bringing Emory University's research funding for the year to $484.3 million, an 18% increase over the previous year.

These awards include National Cancer Institute designation and $4.2 million in funding for Emory Winship Cancer Institute, a $16 million NIH grant to explore fundamental questions about how vaccines work, $14.5 million from the NIH to fund a clinical trial of progesterone for traumatic brain injury (a treatment pioneered at Emory), $7.5 million to study cancer imaging, and $6 million to study environmental causes of Parkinson’s, among many others.

Each of these grants represents a belief on the funding agencies' part that their investment in Emory will yield important dividends for patients. Each grant also represents an investment by the Woodruff Health Sciences Center in overhead costs to support such research. Last year, the total cash loss for such unrecovered costs of research in the WHSC totaled $97.7 million.

Table of Contents

emory health fall